GlassScriptPhysician profile
Gregory Randall Scott
NPI 1255315123
$2,647.98
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,958 · 2022: $690.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $509.23 | 2021-2022 | |
| Esperion Therapeutics, INC. | $297.21 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $242.64 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.06 | 2021-2022 | |
| Novo Nordisk INC | $186.35 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $162.38 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $144.93 | 2021-2022 | |
| Amgen INC. | $139.75 | 2021-2022 | |
| Amarin Pharma, INC. | $134.79 | 2021 | |
| Boston Scientific Corporation | $130.53 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $127.33 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $96.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.84 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $62.27 | 2021 | |
| Abbott Laboratories | $51.28 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.22 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $22.55 | 2021 | |
| Pfizer INC. | $20.80 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.